187 related articles for article (PubMed ID: 37452282)
1. Urinary N-Acetyl-Beta-D-Glucosaminidase levels predict immunoglobulin a nephropathy remission status.
Liu X; Gong S; Ning Y; Li Y; Zhou H; He L; Lin L; Jin S; Shen Z; Zhu B; Li F; Li J; Tan X; Jiao X; Shi Y; Ding X
BMC Nephrol; 2023 Jul; 24(1):208. PubMed ID: 37452282
[TBL] [Abstract][Full Text] [Related]
2. Does circulating erythropoietin reflect progression of IgA nephropathy? Comparison with urinary N-acetyl-beta-D-glucosaminidase.
Machiguchi T; Yoshida H; Yonemoto S; Minakata T; Nomura K; Muso E; Tamura T; Sasayama S
Nephrol Dial Transplant; 1999 Mar; 14(3):635-40. PubMed ID: 10193812
[TBL] [Abstract][Full Text] [Related]
3. DCR2, a Cellular Senescent Molecule, Is a Novel Marker for Assessing Tubulointerstitial Fibrosis in Patients with Immunoglobulin A Nephropathy.
Chen J; Hu W; Xiao F; Lin L; Chen K; Wang L; Wang X; He Y
Kidney Blood Press Res; 2019; 44(5):1063-1074. PubMed ID: 31487717
[TBL] [Abstract][Full Text] [Related]
4. Combining Serum Cystatin C and Urinary N-Acetyl-Beta-D-Glucosaminidase Improves the Precision for Acute Kidney Injury Diagnosis after Resection of Intracranial Space-Occupying Lesions.
Deng Y; Ma J; Hou Y; Zhou D; Hou T; Li J; Liang S; Tan N; Chen C
Kidney Blood Press Res; 2020; 45(1):142-156. PubMed ID: 31927548
[TBL] [Abstract][Full Text] [Related]
5. Prediction of acute kidney injury after total aortic arch replacement with serum cystatin C and urine N-acetyl-β-d-glucosaminidase: A prospective observational study.
Fang M; Li J; Fang H; Wu J; Wu Z; He L; Deng J; Chen C
Clin Chim Acta; 2023 Jan; 539():105-113. PubMed ID: 36521552
[TBL] [Abstract][Full Text] [Related]
6. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy.
Ding H; He Y; Li K; Yang J; Li X; Lu R; Gao W
Clin Immunol; 2007 May; 123(2):227-34. PubMed ID: 17360238
[TBL] [Abstract][Full Text] [Related]
7. A nomogram incorporating functional and tubular damage biomarkers to predict the risk of acute kidney injury for septic patients.
Ma J; Deng Y; Lao H; Ouyang X; Liang S; Wang Y; Yao F; Deng Y; Chen C
BMC Nephrol; 2021 May; 22(1):176. PubMed ID: 33985459
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.
Mise K; Hoshino J; Ueno T; Hazue R; Hasegawa J; Sekine A; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
Clin J Am Soc Nephrol; 2016 Apr; 11(4):593-601. PubMed ID: 26801478
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of clinically available renal biomarkers in critically ill adults: a prospective multicenter observational study.
Deng Y; Chi R; Chen S; Ye H; Yuan J; Wang L; Zhai Y; Gao L; Zhang D; Hu L; Lv B; Long Y; Sun C; Yang X; Zou X; Chen C
Crit Care; 2017 Mar; 21(1):46. PubMed ID: 28264714
[TBL] [Abstract][Full Text] [Related]
10. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
[TBL] [Abstract][Full Text] [Related]
11. Urinary Soluble CD163 Levels Predict IgA Nephropathy Remission Status.
Gong S; Jin S; Li Y; Jiang W; Zhang Z; Shen Z; Wang J; Zhou H; Liu X; Xu X; Ding X; Shi Y; Liu H
Front Immunol; 2021; 12():769802. PubMed ID: 35003086
[TBL] [Abstract][Full Text] [Related]
12. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
[TBL] [Abstract][Full Text] [Related]
13. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
[TBL] [Abstract][Full Text] [Related]
14. The role of urinary N-acetyl-β-D-glucosaminidase in early detection of acute kidney injury among pediatric patients with neoplastic disorders in a retrospective study.
Bíró E; Szegedi I; Kiss C; Oláh AV; Dockrell M; Price RG; Szabó T
BMC Pediatr; 2022 Jul; 22(1):429. PubMed ID: 35854249
[TBL] [Abstract][Full Text] [Related]
15. Urinary protein markers predict the severity of renal histological lesions in children with mesangial proliferative glomerulonephritis.
Li Y; Wang J; Zhu X; Feng Q; Li X; Feng X
BMC Nephrol; 2012 May; 13():29. PubMed ID: 22607047
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis inhibitor of macrophage as a biomarker for disease activity in Japanese children with IgA nephropathy and Henoch-Schönlein purpura nephritis.
Irabu H; Shimizu M; Kaneko S; Inoue N; Mizuta M; Tasaki Y; Ohta K; Yachie A; Wada T
Pediatr Res; 2021 Feb; 89(3):667-672. PubMed ID: 32408340
[TBL] [Abstract][Full Text] [Related]
17. Tubular reabsorption of high, middle and low molecular weight proteins according to the tubulo-interstitial damage marker N-acetyl-β-D-glucosaminidase in glomerulonephritis.
Bazzi C; Rizza V; Olivieri G; Casellato D; D'Amico G
J Nephrol; 2015 Oct; 28(5):541-8. PubMed ID: 25227764
[TBL] [Abstract][Full Text] [Related]
18. Elevated urinary N-acetyl-β-D-glucosaminidase is associated with high glycoalbumin-to-hemoglobin A1c ratio in type 1 diabetes patients with early diabetic kidney disease.
Hong N; Lee M; Park S; Lee YH; Jin SM; Kim JH; Lee BW
Sci Rep; 2018 Apr; 8(1):6710. PubMed ID: 29712934
[TBL] [Abstract][Full Text] [Related]
19. Urinary enzymatic markers (N-acetyl-beta-D-glucosaminidase) in assessing the tubulointerstitial compartment in chronic glomerulonephritis related to odontogenic foci.
Velciov S; Gluhovschi G; Timar R; Gluhovschi C; Petrica L; Bob F; Bozdog G; Pricop M; Gluhovschi A; Cornianu M; Potencz E; Timar B; Kaycsa A
Wien Klin Wochenschr; 2016 Feb; 128(3-4):102-8. PubMed ID: 26377174
[TBL] [Abstract][Full Text] [Related]
20. Assessment and prediction of acute kidney injury in patients with decompensated cirrhosis with serum cystatin C and urine N-acetyl-β-D-glucosaminidase.
Kim TH; Lee HA; Seo YS; Lee YR; Yim SY; Lee YS; Suh SJ; Jung YK; Kim JH; An H; Yim HJ; Yeon JE; Byun KS; Um SH;
J Gastroenterol Hepatol; 2019 Jan; 34(1):234-240. PubMed ID: 30062791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
